Cohen & Steers, Inc.

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VSMPX has a market cap of 2T. Regarding current trading prices, CNS is priced at $63.16, while VSMPX trades at $305.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VSMPX's P/E ratio is 26.30. In terms of profitability, CNS's ROE is +0.29%, compared to VSMPX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to VSMPX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VSMPX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VITSX has a market cap of 2T. Regarding current trading prices, CNS is priced at $63.16, while VITSX trades at $163.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VITSX's P/E ratio is 26.30. In terms of profitability, CNS's ROE is +0.29%, compared to VITSX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VITSX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VITSX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VTSAX has a market cap of 2T. Regarding current trading prices, CNS is priced at $63.16, while VTSAX trades at $163.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VTSAX's P/E ratio is 26.30. In terms of profitability, CNS's ROE is +0.29%, compared to VTSAX's ROE of +0.08%. Regarding short-term risk, CNS is more volatile compared to VTSAX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VTSAX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, PMFLX has a market cap of 1.9T. Regarding current trading prices, CNS is priced at $63.16, while PMFLX trades at $10.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas PMFLX's P/E ratio is N/A. In terms of profitability, CNS's ROE is +0.29%, compared to PMFLX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to PMFLX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check PMFLX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VFINX has a market cap of 1.5T. Regarding current trading prices, CNS is priced at $63.16, while VFINX trades at $629.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VFINX's P/E ratio is 27.01. In terms of profitability, CNS's ROE is +0.29%, compared to VFINX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VFINX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VFINX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VOO has a market cap of 1.5T. Regarding current trading prices, CNS is priced at $63.16, while VOO trades at $624.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VOO's P/E ratio is 26.98. In terms of profitability, CNS's ROE is +0.29%, compared to VOO's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VOO. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VOO's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VFFSX has a market cap of 1.4T. Regarding current trading prices, CNS is priced at $63.16, while VFFSX trades at $333.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VFFSX's P/E ratio is 27.00. In terms of profitability, CNS's ROE is +0.29%, compared to VFFSX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to VFFSX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VFFSX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VFIAX has a market cap of 1.4T. Regarding current trading prices, CNS is priced at $63.16, while VFIAX trades at $629.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VFIAX's P/E ratio is 27.00. In terms of profitability, CNS's ROE is +0.29%, compared to VFIAX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VFIAX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VFIAX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, BCTK has a market cap of 1.1T. Regarding current trading prices, CNS is priced at $63.16, while BCTK trades at $24.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas BCTK's P/E ratio is 44.23. In terms of profitability, CNS's ROE is +0.29%, compared to BCTK's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to BCTK. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check BCTK's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, IVV has a market cap of 747.9B. Regarding current trading prices, CNS is priced at $63.16, while IVV trades at $682.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas IVV's P/E ratio is 26.94. In terms of profitability, CNS's ROE is +0.29%, compared to IVV's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to IVV. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check IVV's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, FXAIX has a market cap of 714.9B. Regarding current trading prices, CNS is priced at $63.16, while FXAIX trades at $236.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas FXAIX's P/E ratio is N/A. In terms of profitability, CNS's ROE is +0.29%, compared to FXAIX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to FXAIX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check FXAIX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, SPY has a market cap of 675.8B. Regarding current trading prices, CNS is priced at $63.16, while SPY trades at $679.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas SPY's P/E ratio is 26.94. In terms of profitability, CNS's ROE is +0.29%, compared to SPY's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to SPY. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check SPY's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VXUS has a market cap of 583.1B. Regarding current trading prices, CNS is priced at $63.16, while VXUS trades at $81.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VXUS's P/E ratio is 17.63. In terms of profitability, CNS's ROE is +0.29%, compared to VXUS's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VXUS. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VXUS's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VTSNX has a market cap of 582.3B. Regarding current trading prices, CNS is priced at $63.16, while VTSNX trades at $174.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VTSNX's P/E ratio is 17.58. In terms of profitability, CNS's ROE is +0.29%, compared to VTSNX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VTSNX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VTSNX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VTPSX has a market cap of 582.3B. Regarding current trading prices, CNS is priced at $63.16, while VTPSX trades at $174.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VTPSX's P/E ratio is 17.58. In terms of profitability, CNS's ROE is +0.29%, compared to VTPSX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VTPSX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VTPSX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VTIAX has a market cap of 581.7B. Regarding current trading prices, CNS is priced at $63.16, while VTIAX trades at $43.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VTIAX's P/E ratio is 17.59. In terms of profitability, CNS's ROE is +0.29%, compared to VTIAX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VTIAX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VTIAX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VTI has a market cap of 573.6B. Regarding current trading prices, CNS is priced at $63.16, while VTI trades at $335.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VTI's P/E ratio is 26.26. In terms of profitability, CNS's ROE is +0.29%, compared to VTI's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VTI. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VTI's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, BMOP has a market cap of 436.2B. Regarding current trading prices, CNS is priced at $63.16, while BMOP trades at $24.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas BMOP's P/E ratio is N/A. In terms of profitability, CNS's ROE is +0.29%, compared to BMOP's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to BMOP. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check BMOP's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, QQQ has a market cap of 375.7B. Regarding current trading prices, CNS is priced at $63.16, while QQQ trades at $611.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas QQQ's P/E ratio is 32.28. In terms of profitability, CNS's ROE is +0.29%, compared to QQQ's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to QQQ. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check QQQ's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VINIX has a market cap of 325.3B. Regarding current trading prices, CNS is priced at $63.16, while VINIX trades at $545.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VINIX's P/E ratio is 26.81. In terms of profitability, CNS's ROE is +0.29%, compared to VINIX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VINIX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VINIX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VUG has a market cap of 320.9B. Regarding current trading prices, CNS is priced at $63.16, while VUG trades at $461.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VUG's P/E ratio is 33.97. In terms of profitability, CNS's ROE is +0.29%, compared to VUG's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VUG. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VUG's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VIGIX has a market cap of 317.9B. Regarding current trading prices, CNS is priced at $63.16, while VIGIX trades at $237.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VIGIX's P/E ratio is 33.85. In terms of profitability, CNS's ROE is +0.29%, compared to VIGIX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VIGIX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VIGIX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VIGAX has a market cap of 317.9B. Regarding current trading prices, CNS is priced at $63.16, while VIGAX trades at $237.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VIGAX's P/E ratio is 33.85. In terms of profitability, CNS's ROE is +0.29%, compared to VIGAX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VIGAX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VIGAX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VIIIX has a market cap of 317.3B. Regarding current trading prices, CNS is priced at $63.16, while VIIIX trades at $545.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VIIIX's P/E ratio is 26.81. In terms of profitability, CNS's ROE is +0.29%, compared to VIIIX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VIIIX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VIIIX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VEA has a market cap of 302.8B. Regarding current trading prices, CNS is priced at $63.16, while VEA trades at $67.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VEA's P/E ratio is 18.62. In terms of profitability, CNS's ROE is +0.29%, compared to VEA's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VEA. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VEA's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, ABALX has a market cap of 284.9B. Regarding current trading prices, CNS is priced at $63.16, while ABALX trades at $38.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas ABALX's P/E ratio is 26.84. In terms of profitability, CNS's ROE is +0.29%, compared to ABALX's ROE of +0.13%. Regarding short-term risk, CNS is more volatile compared to ABALX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check ABALX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, BALFX has a market cap of 284.9B. Regarding current trading prices, CNS is priced at $63.16, while BALFX trades at $38.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas BALFX's P/E ratio is 26.84. In terms of profitability, CNS's ROE is +0.29%, compared to BALFX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to BALFX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check BALFX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VTMGX has a market cap of 282.2B. Regarding current trading prices, CNS is priced at $63.16, while VTMGX trades at $21.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VTMGX's P/E ratio is 18.59. In terms of profitability, CNS's ROE is +0.29%, compared to VTMGX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VTMGX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VTMGX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VTMNX has a market cap of 282.2B. Regarding current trading prices, CNS is priced at $63.16, while VTMNX trades at $21.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VTMNX's P/E ratio is 18.59. In terms of profitability, CNS's ROE is +0.29%, compared to VTMNX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VTMNX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VTMNX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VDIPX has a market cap of 281.8B. Regarding current trading prices, CNS is priced at $63.16, while VDIPX trades at $34.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VDIPX's P/E ratio is 18.59. In terms of profitability, CNS's ROE is +0.29%, compared to VDIPX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VDIPX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VDIPX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, RLBGX has a market cap of 279.8B. Regarding current trading prices, CNS is priced at $63.16, while RLBGX trades at $38.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas RLBGX's P/E ratio is 26.84. In terms of profitability, CNS's ROE is +0.29%, compared to RLBGX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to RLBGX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check RLBGX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, CLBAX has a market cap of 279B. Regarding current trading prices, CNS is priced at $63.16, while CLBAX trades at $38.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas CLBAX's P/E ratio is 26.84. In terms of profitability, CNS's ROE is +0.29%, compared to CLBAX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to CLBAX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check CLBAX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, AMBFX has a market cap of 279B. Regarding current trading prices, CNS is priced at $63.16, while AMBFX trades at $38.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas AMBFX's P/E ratio is 26.84. In terms of profitability, CNS's ROE is +0.29%, compared to AMBFX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to AMBFX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check AMBFX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, AFMBX has a market cap of 279B. Regarding current trading prices, CNS is priced at $63.16, while AFMBX trades at $38.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas AFMBX's P/E ratio is 26.84. In terms of profitability, CNS's ROE is +0.29%, compared to AFMBX's ROE of +0.13%. Regarding short-term risk, CNS is more volatile compared to AFMBX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check AFMBX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, RGAGX has a market cap of 275.5B. Regarding current trading prices, CNS is priced at $63.16, while RGAGX trades at $77.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas RGAGX's P/E ratio is 28.78. In terms of profitability, CNS's ROE is +0.29%, compared to RGAGX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to RGAGX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check RGAGX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, GAFFX has a market cap of 275.2B. Regarding current trading prices, CNS is priced at $63.16, while GAFFX trades at $77.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas GAFFX's P/E ratio is 28.77. In terms of profitability, CNS's ROE is +0.29%, compared to GAFFX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to GAFFX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check GAFFX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, AGTHX has a market cap of 274.9B. Regarding current trading prices, CNS is priced at $63.16, while AGTHX trades at $77.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas AGTHX's P/E ratio is 28.75. In terms of profitability, CNS's ROE is +0.29%, compared to AGTHX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to AGTHX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check AGTHX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, GFFFX has a market cap of 273.9B. Regarding current trading prices, CNS is priced at $63.16, while GFFFX trades at $77.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas GFFFX's P/E ratio is 28.77. In terms of profitability, CNS's ROE is +0.29%, compared to GFFFX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to GFFFX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check GFFFX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, GFAFX has a market cap of 272B. Regarding current trading prices, CNS is priced at $63.16, while GFAFX trades at $76.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas GFAFX's P/E ratio is 28.74. In terms of profitability, CNS's ROE is +0.29%, compared to GFAFX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to GFAFX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check GFAFX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, CGFAX has a market cap of 269.5B. Regarding current trading prices, CNS is priced at $63.16, while CGFAX trades at $76.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas CGFAX's P/E ratio is 28.75. In terms of profitability, CNS's ROE is +0.29%, compared to CGFAX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to CGFAX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check CGFAX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, RGABX has a market cap of 240.2B. Regarding current trading prices, CNS is priced at $63.16, while RGABX trades at $67.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas RGABX's P/E ratio is 28.69. In terms of profitability, CNS's ROE is +0.29%, compared to RGABX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to RGABX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check RGABX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VTV has a market cap of 237.7B. Regarding current trading prices, CNS is priced at $63.16, while VTV trades at $201.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VTV's P/E ratio is 21.32. In terms of profitability, CNS's ROE is +0.29%, compared to VTV's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VTV. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VTV's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, RGAAX has a market cap of 235.7B. Regarding current trading prices, CNS is priced at $63.16, while RGAAX trades at $66.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas RGAAX's P/E ratio is 28.69. In terms of profitability, CNS's ROE is +0.29%, compared to RGAAX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to RGAAX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check RGAAX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, GFACX has a market cap of 229.5B. Regarding current trading prices, CNS is priced at $63.16, while GFACX trades at $64.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas GFACX's P/E ratio is 28.69. In terms of profitability, CNS's ROE is +0.29%, compared to GFACX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to GFACX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check GFACX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VVIAX has a market cap of 226.8B. Regarding current trading prices, CNS is priced at $63.16, while VVIAX trades at $78.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VVIAX's P/E ratio is 21.50. In terms of profitability, CNS's ROE is +0.29%, compared to VVIAX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VVIAX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VVIAX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, LACG has a market cap of 218.2B. Regarding current trading prices, CNS is priced at $63.16, while LACG trades at $7.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas LACG's P/E ratio is N/A. In terms of profitability, CNS's ROE is +0.29%, compared to LACG's ROE of +0.00%. Regarding short-term risk, CNS is less volatile compared to LACG. This indicates potentially lower risk in terms of short-term price fluctuations for CNS.Check LACG's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, FCTDX has a market cap of 215.4B. Regarding current trading prices, CNS is priced at $63.16, while FCTDX trades at $20.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas FCTDX's P/E ratio is N/A. In terms of profitability, CNS's ROE is +0.29%, compared to FCTDX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to FCTDX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check FCTDX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VO has a market cap of 214.4B. Regarding current trading prices, CNS is priced at $63.16, while VO trades at $296.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VO's P/E ratio is 23.46. In terms of profitability, CNS's ROE is +0.29%, compared to VO's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VO. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VO's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, ODIDX has a market cap of 212.2B. Regarding current trading prices, CNS is priced at $63.16, while ODIDX trades at $8.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas ODIDX's P/E ratio is N/A. In terms of profitability, CNS's ROE is +0.29%, compared to ODIDX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to ODIDX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check ODIDX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VMCPX has a market cap of 198.2B. Regarding current trading prices, CNS is priced at $63.16, while VMCPX trades at $400.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VMCPX's P/E ratio is 23.59. In terms of profitability, CNS's ROE is +0.29%, compared to VMCPX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VMCPX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VMCPX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VMCIX has a market cap of 198.2B. Regarding current trading prices, CNS is priced at $63.16, while VMCIX trades at $81.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VMCIX's P/E ratio is 23.59. In terms of profitability, CNS's ROE is +0.29%, compared to VMCIX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VMCIX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VMCIX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VIMAX has a market cap of 198.2B. Regarding current trading prices, CNS is priced at $63.16, while VIMAX trades at $367.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VIMAX's P/E ratio is 23.59. In terms of profitability, CNS's ROE is +0.29%, compared to VIMAX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VIMAX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VIMAX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, MER-PK has a market cap of 193.2B. Regarding current trading prices, CNS is priced at $63.16, while MER-PK trades at $25.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas MER-PK's P/E ratio is N/A. In terms of profitability, CNS's ROE is +0.29%, compared to MER-PK's ROE of +0.05%. Regarding short-term risk, CNS is more volatile compared to MER-PK. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check MER-PK's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, AICFX has a market cap of 183.9B. Regarding current trading prices, CNS is priced at $63.16, while AICFX trades at $62.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas AICFX's P/E ratio is 27.51. In terms of profitability, CNS's ROE is +0.29%, compared to AICFX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to AICFX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check AICFX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, RICBX has a market cap of 183.9B. Regarding current trading prices, CNS is priced at $63.16, while RICBX trades at $62.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas RICBX's P/E ratio is 27.51. In terms of profitability, CNS's ROE is +0.29%, compared to RICBX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to RICBX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check RICBX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, RICAX has a market cap of 183.9B. Regarding current trading prices, CNS is priced at $63.16, while RICAX trades at $61.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas RICAX's P/E ratio is 27.51. In terms of profitability, CNS's ROE is +0.29%, compared to RICAX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to RICAX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check RICAX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, FFICX has a market cap of 178.6B. Regarding current trading prices, CNS is priced at $63.16, while FFICX trades at $62.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas FFICX's P/E ratio is 27.52. In terms of profitability, CNS's ROE is +0.29%, compared to FFICX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to FFICX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check FFICX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, AICCX has a market cap of 178.6B. Regarding current trading prices, CNS is priced at $63.16, while AICCX trades at $61.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas AICCX's P/E ratio is 27.51. In terms of profitability, CNS's ROE is +0.29%, compared to AICCX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to AICCX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check AICCX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, IEFA has a market cap of 176.8B. Regarding current trading prices, CNS is priced at $63.16, while IEFA trades at $95.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas IEFA's P/E ratio is 18.43. In terms of profitability, CNS's ROE is +0.29%, compared to IEFA's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to IEFA. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check IEFA's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, C-PN has a market cap of 175.9B. Regarding current trading prices, CNS is priced at $63.16, while C-PN trades at $30.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas C-PN's P/E ratio is N/A. In terms of profitability, CNS's ROE is +0.29%, compared to C-PN's ROE of +0.07%. Regarding short-term risk, CNS is more volatile compared to C-PN. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check C-PN's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, FINFX has a market cap of 172.8B. Regarding current trading prices, CNS is priced at $63.16, while FINFX trades at $93.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas FINFX's P/E ratio is 27.28. In terms of profitability, CNS's ROE is +0.29%, compared to FINFX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to FINFX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check FINFX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, FNPFX has a market cap of 172B. Regarding current trading prices, CNS is priced at $63.16, while FNPFX trades at $70.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas FNPFX's P/E ratio is 26.18. In terms of profitability, CNS's ROE is +0.29%, compared to FNPFX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to FNPFX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check FNPFX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, CFNAX has a market cap of 167.3B. Regarding current trading prices, CNS is priced at $63.16, while CFNAX trades at $93.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas CFNAX's P/E ratio is 27.27. In terms of profitability, CNS's ROE is +0.29%, compared to CFNAX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to CFNAX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check CFNAX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, FUNFX has a market cap of 167.3B. Regarding current trading prices, CNS is priced at $63.16, while FUNFX trades at $93.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas FUNFX's P/E ratio is 27.28. In terms of profitability, CNS's ROE is +0.29%, compared to FUNFX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to FUNFX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check FUNFX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, AIVSX has a market cap of 165.9B. Regarding current trading prices, CNS is priced at $63.16, while AIVSX trades at $62.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas AIVSX's P/E ratio is 27.52. In terms of profitability, CNS's ROE is +0.29%, compared to AIVSX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to AIVSX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check AIVSX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, CICAX has a market cap of 165.9B. Regarding current trading prices, CNS is priced at $63.16, while CICAX trades at $62.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas CICAX's P/E ratio is 27.51. In terms of profitability, CNS's ROE is +0.29%, compared to CICAX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to CICAX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check CICAX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, RNPCX has a market cap of 165.8B. Regarding current trading prices, CNS is priced at $63.16, while RNPCX trades at $67.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas RNPCX's P/E ratio is 26.13. In terms of profitability, CNS's ROE is +0.29%, compared to RNPCX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to RNPCX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check RNPCX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VSCIX has a market cap of 164.6B. Regarding current trading prices, CNS is priced at $63.16, while VSCIX trades at $130.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VSCIX's P/E ratio is 21.36. In terms of profitability, CNS's ROE is +0.29%, compared to VSCIX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VSCIX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VSCIX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VSMAX has a market cap of 164.6B. Regarding current trading prices, CNS is priced at $63.16, while VSMAX trades at $130.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VSMAX's P/E ratio is 21.36. In terms of profitability, CNS's ROE is +0.29%, compared to VSMAX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VSMAX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VSMAX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VB has a market cap of 164B. Regarding current trading prices, CNS is priced at $63.16, while VB trades at $272.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VB's P/E ratio is 21.28. In terms of profitability, CNS's ROE is +0.29%, compared to VB's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VB. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VB's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, GLD has a market cap of 161.1B. Regarding current trading prices, CNS is priced at $63.16, while GLD trades at $437.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas GLD's P/E ratio is -46.54. In terms of profitability, CNS's ROE is +0.29%, compared to GLD's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to GLD. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check GLD's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, FCNKX has a market cap of 159.3B. Regarding current trading prices, CNS is priced at $63.16, while FCNKX trades at $24.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas FCNKX's P/E ratio is N/A. In terms of profitability, CNS's ROE is +0.29%, compared to FCNKX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to FCNKX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check FCNKX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, IEMG has a market cap of 158.2B. Regarding current trading prices, CNS is priced at $63.16, while IEMG trades at $74.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas IEMG's P/E ratio is 16.63. In terms of profitability, CNS's ROE is +0.29%, compared to IEMG's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to IEMG. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check IEMG's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, FCNTX has a market cap of 157.8B. Regarding current trading prices, CNS is priced at $63.16, while FCNTX trades at $24.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas FCNTX's P/E ratio is N/A. In terms of profitability, CNS's ROE is +0.29%, compared to FCNTX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to FCNTX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check FCNTX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, FPMAX has a market cap of 155.5B. Regarding current trading prices, CNS is priced at $63.16, while FPMAX trades at $10.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas FPMAX's P/E ratio is N/A. In terms of profitability, CNS's ROE is +0.29%, compared to FPMAX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to FPMAX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check FPMAX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, BLK has a market cap of 155.4B. Regarding current trading prices, CNS is priced at $63.16, while BLK trades at $999.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas BLK's P/E ratio is 28.33. In terms of profitability, CNS's ROE is +0.29%, compared to BLK's ROE of +0.11%. Regarding short-term risk, CNS is more volatile compared to BLK. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check BLK's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, AFIFX has a market cap of 153.9B. Regarding current trading prices, CNS is priced at $63.16, while AFIFX trades at $93.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas AFIFX's P/E ratio is 27.28. In terms of profitability, CNS's ROE is +0.29%, compared to AFIFX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to AFIFX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check AFIFX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, ANCFX has a market cap of 153.9B. Regarding current trading prices, CNS is priced at $63.16, while ANCFX trades at $93.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas ANCFX's P/E ratio is 27.27. In terms of profitability, CNS's ROE is +0.29%, compared to ANCFX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to ANCFX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check ANCFX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, RFNCX has a market cap of 153.9B. Regarding current trading prices, CNS is priced at $63.16, while RFNCX trades at $93.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas RFNCX's P/E ratio is 27.27. In terms of profitability, CNS's ROE is +0.29%, compared to RFNCX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to RFNCX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check RFNCX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, ANWPX has a market cap of 152.9B. Regarding current trading prices, CNS is priced at $63.16, while ANWPX trades at $70.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas ANWPX's P/E ratio is 26.15. In terms of profitability, CNS's ROE is +0.29%, compared to ANWPX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to ANWPX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check ANWPX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, NPFFX has a market cap of 152.7B. Regarding current trading prices, CNS is priced at $63.16, while NPFFX trades at $69.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas NPFFX's P/E ratio is 26.15. In terms of profitability, CNS's ROE is +0.29%, compared to NPFFX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to NPFFX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check NPFFX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, RNPGX has a market cap of 152.7B. Regarding current trading prices, CNS is priced at $63.16, while RNPGX trades at $70.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas RNPGX's P/E ratio is 26.18. In terms of profitability, CNS's ROE is +0.29%, compared to RNPGX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to RNPGX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check RNPGX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, GRAG has a market cap of 150.9B. Regarding current trading prices, CNS is priced at $63.16, while GRAG trades at $6.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas GRAG's P/E ratio is N/A. In terms of profitability, CNS's ROE is +0.29%, compared to GRAG's ROE of +0.00%. Regarding short-term risk, CNS is less volatile compared to GRAG. This indicates potentially lower risk in terms of short-term price fluctuations for CNS.Check GRAG's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, WGIFX has a market cap of 149.9B. Regarding current trading prices, CNS is priced at $63.16, while WGIFX trades at $74.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas WGIFX's P/E ratio is 24.21. In terms of profitability, CNS's ROE is +0.29%, compared to WGIFX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to WGIFX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check WGIFX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, FIFAX has a market cap of 149.2B. Regarding current trading prices, CNS is priced at $63.16, while FIFAX trades at $27.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas FIFAX's P/E ratio is 19.34. In terms of profitability, CNS's ROE is +0.29%, compared to FIFAX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to FIFAX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check FIFAX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, RERGX has a market cap of 147.9B. Regarding current trading prices, CNS is priced at $63.16, while RERGX trades at $62.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas RERGX's P/E ratio is 19.96. In terms of profitability, CNS's ROE is +0.29%, compared to RERGX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to RERGX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check RERGX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, AWSHX has a market cap of 147B. Regarding current trading prices, CNS is priced at $63.16, while AWSHX trades at $65.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas AWSHX's P/E ratio is 25.68. In terms of profitability, CNS's ROE is +0.29%, compared to AWSHX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to AWSHX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check AWSHX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VWO has a market cap of 146.9B. Regarding current trading prices, CNS is priced at $63.16, while VWO trades at $56.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VWO's P/E ratio is 15.33. In terms of profitability, CNS's ROE is +0.29%, compared to VWO's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VWO. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VWO's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, RWMFX has a market cap of 146.9B. Regarding current trading prices, CNS is priced at $63.16, while RWMFX trades at $65.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas RWMFX's P/E ratio is 25.68. In terms of profitability, CNS's ROE is +0.29%, compared to RWMFX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to RWMFX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check RWMFX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, FWMIX has a market cap of 146.9B. Regarding current trading prices, CNS is priced at $63.16, while FWMIX trades at $65.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas FWMIX's P/E ratio is 25.68. In terms of profitability, CNS's ROE is +0.29%, compared to FWMIX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to FWMIX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check FWMIX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, CWMAX has a market cap of 146.4B. Regarding current trading prices, CNS is priced at $63.16, while CWMAX trades at $65.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas CWMAX's P/E ratio is 25.68. In terms of profitability, CNS's ROE is +0.29%, compared to CWMAX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to CWMAX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check CWMAX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VEMRX has a market cap of 146.4B. Regarding current trading prices, CNS is priced at $63.16, while VEMRX trades at $119.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VEMRX's P/E ratio is 15.27. In terms of profitability, CNS's ROE is +0.29%, compared to VEMRX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VEMRX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VEMRX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, VEMAX has a market cap of 146.3B. Regarding current trading prices, CNS is priced at $63.16, while VEMAX trades at $47.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas VEMAX's P/E ratio is 15.27. In terms of profitability, CNS's ROE is +0.29%, compared to VEMAX's ROE of +0.00%. Regarding short-term risk, CNS is more volatile compared to VEMAX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check VEMAX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, WSHFX has a market cap of 146.1B. Regarding current trading prices, CNS is priced at $63.16, while WSHFX trades at $64.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas WSHFX's P/E ratio is 25.68. In terms of profitability, CNS's ROE is +0.29%, compared to WSHFX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to WSHFX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check WSHFX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, WSHCX has a market cap of 143.9B. Regarding current trading prices, CNS is priced at $63.16, while WSHCX trades at $63.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas WSHCX's P/E ratio is 25.67. In terms of profitability, CNS's ROE is +0.29%, compared to WSHCX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to WSHCX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check WSHCX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, RWMBX has a market cap of 143.4B. Regarding current trading prices, CNS is priced at $63.16, while RWMBX trades at $63.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas RWMBX's P/E ratio is 25.67. In terms of profitability, CNS's ROE is +0.29%, compared to RWMBX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to RWMBX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check RWMBX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, RERHX has a market cap of 140.9B. Regarding current trading prices, CNS is priced at $63.16, while RERHX trades at $61.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas RERHX's P/E ratio is 19.95. In terms of profitability, CNS's ROE is +0.29%, compared to RERHX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to RERHX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check RERHX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, AEPFX has a market cap of 140.9B. Regarding current trading prices, CNS is priced at $63.16, while AEPFX trades at $62.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas AEPFX's P/E ratio is 19.95. In terms of profitability, CNS's ROE is +0.29%, compared to AEPFX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to AEPFX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check AEPFX's competition here

CNS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNS stands at 3.2B. In comparison, AEGFX has a market cap of 140.9B. Regarding current trading prices, CNS is priced at $63.16, while AEGFX trades at $62.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNS currently has a P/E ratio of 20.93, whereas AEGFX's P/E ratio is 19.93. In terms of profitability, CNS's ROE is +0.29%, compared to AEGFX's ROE of N/A. Regarding short-term risk, CNS is more volatile compared to AEGFX. This indicates potentially higher risk in terms of short-term price fluctuations for CNS.Check AEGFX's competition here